S100A10 expression in thyroid neoplasms originating from the follicular epithelium: Contribution to the aggressive characteristic of anaplastic carcinoma

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2679-2683

  Ito, Yasuhiro ^a   Arai, Kazumori ^b   Nozawa, Ryushi ^c   Yoshida, Hiroshi ^a   Higashiyama, Takuya ^a   Takamura, Yuuki ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b SHIZUOKA GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Annexin II; Immunohistochemistry; S100A10; Thyroid carcinoma

Indexed keywords

LIPOCORTIN 2; PROTEIN S 100; S100A10 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ANNEXIN A2; CARCINOMA; CARCINOMA, PAPILLARY; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; S100 PROTEINS; THYROID NEOPLASMS;

EID: 34547726877     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Heizmann CW, Fritz G and Schafer W: S100 proteins: structure, functions, and pathology. Frontiers Biosci 7: 1356-1368, 2002.
2. Domato R: Functional role of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450: 191-231, 1999.
3. Mai J, Finley RL Jr and Waisman DM: Human procthepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem 275: 12806-12812, 2000.
4. Zobiack N, Gerke V and Rescher U: Complex formation and submembranous localization of annexin II and S100A10 in live Hep G2 cells. FEBS lett 560: 137-140, 2001.
5. Kwon M, MacLeod TJ, Zhang Y and Waisman DM: S10A10, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors. Frontiers Biosci 10: 300-325, 2005.
6. Teratani T, Watanabe T, Kuwahara F, Kumagai H, Kkobayashi S, Aoki U, Ishikawa A, Arai K and Nozawa R: Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Lett 175: 71-77, 2002.
7. Domoto T, Miyama Y, Suzuki H, Teratani T, Arai K, Sugiyama T, Takayama T, Mugiya S, Ozono S and Nozawa R: Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 98: 77-82, 2007.
8. Ji J, Zhao L, Wang X, Zhou C, Ding F, Su L, Zhang C, Mao X, Wu M and Liu Z: Differential expression of S100 gene family in human esophageal squamous cell carcinoma. Cancer Res Clin Oncol 130: 480-486, 2004.
9. Aldinger KA, Samaan NA, Ibanez M and Hill CS Jr: Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant-cell carcinoma of the thyroid. Cancer 41: 2267-2275, 1978.
10. Ito T, Seyama T and Mizuno T: Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52: 1369-1373, 1992.
11. Ito Y, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K and Miyauchi A: S100A4 expresssion is an early event of papillary carcinoma of the thyroid. Oncology 67: 397-402, 2004.
12. Ito Y, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K and Miyauchi A: S100A2 and S100A6 in thyroid carcinomas. Histopathology 46: 569-575. 2005.
13. Ito Y, Arai K, Nozawa R, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Kakudo K and Miyauchi A: S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. Pathol Res Pract 201: 551-556, 2005.
14. Fagin JA: Molecular genetics of tumors of thyroid follicular cells. In: The Thyroid, Braveman LE and Utiger RD (eds.). Lippincott Williams and Wilkins Philadelphia PA, USA, pp. 906-927, 2005.
15. Mazafferi EL and Kloos RT: Carcinoma of follicular epithelium: radioiodine and other treatments and outcomes. In: The Thyroid, Braveman LE and Utiger RD (eds.). Lippincott Williams and Wilkins Philadelphia PA, pp. 934-966, 2005.